DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

Abbott

Status: Completed

Conditions: Coronary Disease

Treatments: Device: Multilink Vision™ Stent (CE-labeled)

Study type: Observational

Funder types: Industry

Identifiers

NCT00243438

Version vom 18.7.2003

Details and patient eligibility

About

Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation

Full description

A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women and Men Age >18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent

Exclusion criteria

• No Multi-Link Vision™ Stent implanted, life expectation >9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin

Trial design

1,300 participants in 1 patient group

1

Description:

Patients who have received a Vision stent and who have diabetes and/or complex lesions.

Treatment:

Device: Multilink Vision™ Stent (CE-labeled)